Exosomal miR-493 suppresses MAD2L1 and induces chemoresistance to intraperitoneal paclitaxel therapy in gastric cancer patients with peritoneal metastasis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Exosomal miR-493 suppresses MAD2L1 and induces chemoresistance to intraperitoneal paclitaxel therapy in gastric cancer patients with peritoneal metastasis ; volume:14 ; number:1 ; day:2 ; month:5 ; year:2024 ; pages:1-12 ; date:12.2024
Scientific reports ; 14, Heft 1 (2.5.2024), 1-12, 12.2024
- Creator
-
Makinoya, Masahiro
Miyatani, Kozo
Matsumi, Yoshiaki
Sakano, Yu
Shimizu, Shota
Shishido, Yuji
Hanaki, Takehiko
Kihara, Kyoichi
Matsunaga, Tomoyuki
Yamamoto, Manabu
Tokuyasu, Naruo
Takano, Shuichi
Sakamoto, Teruhisa
Hasegawa, Toshimichi
Saito, Hiroaki
Nakayama, Yuji
Osaki, Mitsuhiko
Okada, Futoshi
Fujiwara, Yoshiyuki
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-60967-x
- URN
-
urn:nbn:de:101:1-2407132104527.263936255693
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Makinoya, Masahiro
- Miyatani, Kozo
- Matsumi, Yoshiaki
- Sakano, Yu
- Shimizu, Shota
- Shishido, Yuji
- Hanaki, Takehiko
- Kihara, Kyoichi
- Matsunaga, Tomoyuki
- Yamamoto, Manabu
- Tokuyasu, Naruo
- Takano, Shuichi
- Sakamoto, Teruhisa
- Hasegawa, Toshimichi
- Saito, Hiroaki
- Nakayama, Yuji
- Osaki, Mitsuhiko
- Okada, Futoshi
- Fujiwara, Yoshiyuki
- SpringerLink (Online service)
Other Objects (12)
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies
Perioperative intraperitoneal chemotherapy for peritoneal surface malignancy
Intraperitoneal Activity of Heparin During Peritoneal Dialysis
Cytoreductive surgery without intra-peritoneal chemotherapy for metachronous colorectal peritoneal metastases
Oxaliplatin plus S-1 with intraperitoneal paclitaxel for the treatment of Chinese advanced gastric cancer with peritoneal metastases
Randomized phase III trial of intravenous and intraperitoneal paclitaxel with S-1 versus gemcitabine plus nab-paclitaxel for pancreatic ductal adenocarcinoma with peritoneal metastasis (SP study)
PIPAC : Pressurized IntraPeritoneal Aerosol Chemotherapy - cancer under pressure
Peritoneal carcinomatosis treated with cytoreductive surgery and intraperitoneal chemotherapy
TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
Does adding intraperitoneal paclitaxel to standard intraperitoneal regimen yield incremental survival? A propensity score-matched cohort study
Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies
Perioperative intraperitoneal chemotherapy for peritoneal surface malignancy
Intraperitoneal Activity of Heparin During Peritoneal Dialysis
Cytoreductive surgery without intra-peritoneal chemotherapy for metachronous colorectal peritoneal metastases
Oxaliplatin plus S-1 with intraperitoneal paclitaxel for the treatment of Chinese advanced gastric cancer with peritoneal metastases
Randomized phase III trial of intravenous and intraperitoneal paclitaxel with S-1 versus gemcitabine plus nab-paclitaxel for pancreatic ductal adenocarcinoma with peritoneal metastasis (SP study)
PIPAC : Pressurized IntraPeritoneal Aerosol Chemotherapy - cancer under pressure
Peritoneal carcinomatosis treated with cytoreductive surgery and intraperitoneal chemotherapy
TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
Does adding intraperitoneal paclitaxel to standard intraperitoneal regimen yield incremental survival? A propensity score-matched cohort study
Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies
Perioperative intraperitoneal chemotherapy for peritoneal surface malignancy
Intraperitoneal Activity of Heparin During Peritoneal Dialysis
Cytoreductive surgery without intra-peritoneal chemotherapy for metachronous colorectal peritoneal metastases
Oxaliplatin plus S-1 with intraperitoneal paclitaxel for the treatment of Chinese advanced gastric cancer with peritoneal metastases
Randomized phase III trial of intravenous and intraperitoneal paclitaxel with S-1 versus gemcitabine plus nab-paclitaxel for pancreatic ductal adenocarcinoma with peritoneal metastasis (SP study)
PIPAC : Pressurized IntraPeritoneal Aerosol Chemotherapy - cancer under pressure
Peritoneal carcinomatosis treated with cytoreductive surgery and intraperitoneal chemotherapy
TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
Does adding intraperitoneal paclitaxel to standard intraperitoneal regimen yield incremental survival? A propensity score-matched cohort study